Valuation
26% of the score, 30% here after data gaps
12median 53
Illumina, Inc. is valued at 47x its operating profit, including debt: a very rich multiple.
60x
50x
35x
25x
18x
12x
8x
47x
Full points at 8x or less, none from 60xfull points
ILMNIllumina, Inc.
$269.37+181% 1Y
$269.37
$95.0352 weeks$293.84
RyuScore
Seven criteria, each scored 0 to 100 on a published scale, weighted into one number.
RyuScore 27 out of 100, Weak
Today's price. Only valuation depends on it.
Weak. Illumina, Inc. scores higher than 26% of the 2,231 companies Ryufin scores.
Carried by capital allocation and the balance sheet, held back by valuation and return on capital.
Healthcare median 19 · all companies 55
How the score has moved
At each fiscal year end, from the reports and price of the time61
38
28
26
27
38
27
202020212022202320242025today
The biggest move was down 23 points from 2020 to 2021, mostly return on new capital.
Return on capital
18% of the score, 20% here after data gaps
0median 24
Over 7 years the business earned -10% a year after tax on the capital it uses.
2%
8%
15%
25%
-10%
None at 2% or less, full points from 25%full points
7 years agolatest 16%
Return on new capital
16% of the score, 18% here after data gaps
0median 33
No operating profit over the period, so nothing was earned to reinvest.
Capital allocation
14% of the score, 16% here after data gaps
70median 63
How management spends the money: shares bought back or issued, and whether assets grow faster than the business they serve.
Share countUp 1.1% a year over 5 years: new shares
495%
-3%
1.1%
0 pointsfull points
Assets against salesAssets grew -2.6% a year, sales 6%
10012%
-2%
-8.7%
0 pointsfull points
Cycle position
Taken out: its 12% is shared by the others
n/ano data
Margins have been too thin to measure a cycle against.
Balance sheet
8% of the score, 9% here after data gaps
82median 50
What the debt weighs against the profit that has to carry it.
Net debt to EBITDA0.8x a year of EBITDA
944.5x
0.5x
0.8x
0 pointsfull points
Interest coverOperating profit covers interest 9x
711.5x
12x
8.9x
0 pointsfull points
Earnings quality
6% of the score, 7% here after data gaps
76median 90
Whether the reported profit arrives as cash, and whether the accounts show the usual signs of stretching.
AccrualsCash ran ahead of profit by 3.5% of assets
788%
0%
-8%
-3.5%
0 pointsfull points
Beneish M-score-2.51
75-1.50
-1.78
-2.22
-3.00
-2.51
0 pointsfull points
How the RyuScore works
Each criterion earns 0 to 100 points on the scale drawn under it, and the RyuScore is their average weighted 26, 18, 16, 14, 12, 8 and 6. Scales bend in the company's favour between their ends, so an ordinary figure is never already near zero. For ILMN, cycle position could not be measured from the filings, so it is taken out and the remaining weights scale up.
Built from the company's annual and quarterly filings with the SEC and today's share price. Banks, insurers and property trusts are not scored: their debt is their raw material, so these yardsticks mean something else there. Figures as of 2026-06-28, latest annual report FY2025.
Diagnostics & Research
Ranks #8 of 21 by RyuScore